{ "cik": 1640266, "cik_padded": "0001640266", "entityName": "Voyager Therapeutics, Inc.", "fiscal_years": [ { "accn": "0001104659-26-025197", "filed": "2026-03-09", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2596000.0, "cash": 65300000.0, "eps_diluted": -2.04, "free_cash_flow": -135063000.0, "net_income": -119721000.0, "operating_cash_flow": -132467000.0, "operating_income": -131844000.0, "revenue": 40374000.0, "stockholders_equity": 196081000.0, "total_assets": 252281000.0, "total_liabilities": 56200000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2866162453271862, "revenue_growth_yoy": -0.49533130835864553, "roa_avg2y": -0.37103749858599694, "roa_period_end": -0.474554167773237, "roe_avg2y": -0.4829007685931579, "roe_period_end": -0.6105691015447697 } }, { "accn": "0001104659-26-025197", "filed": "2026-03-09", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3521000.0, "cash": 71367000.0, "eps_diluted": -1.13, "free_cash_flow": -18831000.0, "net_income": -65002000.0, "operating_cash_flow": -15310000.0, "operating_income": -83287000.0, "revenue": 80001000.0, "stockholders_equity": 299760000.0, "total_assets": 393050000.0, "total_liabilities": 93290000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3112156391780091, "net_margin": -0.8125148435644555, "operating_margin": -1.0410744865689179, "revenue_growth_yoy": -0.6800062398003264, "roa_avg2y": -0.17465885472995213, "roa_period_end": -0.16537845057880676, "roe_avg2y": -0.2425085808088345, "roe_period_end": -0.2168468107819589 } }, { "accn": "0001558370-25-002703", "filed": "2026-03-09", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3256000.0, "cash": 68802000.0, "eps_diluted": 2.97, "free_cash_flow": 74663000.0, "net_income": 132330000.0, "operating_cash_flow": 77919000.0, "operating_income": 122014000.0, "revenue": 250008000.0, "stockholders_equity": 236320000.0, "total_assets": 351281000.0, "total_liabilities": 114961000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.4864632701421801, "net_margin": 0.5293030623020063, "operating_margin": 0.48804038270775335, "revenue_growth_yoy": 5.111619038306403, "roa_avg2y": 0.518293817330119, "roa_period_end": 0.3767069667872729, "roe_avg2y": 0.8961197264170109, "roe_period_end": 0.5599610697359513 } }, { "accn": "0001558370-25-002703", "filed": "2026-03-09", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2491000.0, "cash": 98959000.0, "eps_diluted": -1.21, "free_cash_flow": -15000000.0, "net_income": -46408000.0, "operating_cash_flow": -12509000.0, "operating_income": -50837000.0, "revenue": 40907000.0, "stockholders_equity": 59020000.0, "total_assets": 159356000.0, "total_liabilities": 100336000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.7000338868180278, "net_margin": -1.134475762094507, "operating_margin": -1.2427457403378395, "revenue_growth_yoy": 0.09333155151677135, "roa_avg2y": -0.26277777305916294, "roa_period_end": -0.2912221692311554, "roe_avg2y": -0.6024079182216453, "roe_period_end": -0.786309725516774 } }, { "accn": "0001558370-25-002703", "filed": "2025-03-11", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1609000.0, "cash": 117433000.0, "eps_diluted": -1.89, "free_cash_flow": -55134000.0, "net_income": -71197000.0, "operating_cash_flow": -53525000.0, "operating_income": -73618000.0, "revenue": 37415000.0, "stockholders_equity": 95055000.0, "total_assets": 193855000.0, "total_liabilities": 98800000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.039398243122403, "revenue_growth_yoy": -0.7813624888971997, "roa_avg2y": -0.3126521883281845, "roa_period_end": -0.36726935080343553, "roe_avg2y": -0.5710035087719298, "roe_period_end": -0.749008468781232 } }, { "accn": "0001558370-24-001988", "filed": "2024-02-28", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 12097000.0, "cash": 104440000.0, "eps_diluted": 0.98, "free_cash_flow": -108813000.0, "net_income": 36741000.0, "operating_cash_flow": -96716000.0, "operating_income": 27384000.0, "revenue": 171128000.0, "stockholders_equity": 154320000.0, "total_assets": 261584000.0, "total_liabilities": 107264000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6950751684810783, "net_margin": 0.21469893880603994, "operating_margin": 0.1600205693983451, "revenue_growth_yoy": 0.6392984069507908, "roa_avg2y": 0.11922238230598498, "roa_period_end": 0.1404558382775705, "roe_avg2y": 0.28949068675344325, "roe_period_end": 0.23808320373250388 } }, { "accn": "0001558370-23-002989", "filed": "2023-03-07", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 7718000.0, "cash": 86042000.0, "eps_diluted": -1.21, "free_cash_flow": 40948000.0, "net_income": -43597000.0, "operating_cash_flow": 48666000.0, "operating_income": -51679000.0, "revenue": 104391000.0, "stockholders_equity": 99512000.0, "total_assets": 354760000.0, "total_liabilities": 255248000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.5649971862689926, "net_margin": -0.41763178818097346, "operating_margin": -0.49505225546263565, "revenue_growth_yoy": 12.7014043837774, "roa_avg2y": -0.16396352688754373, "roa_period_end": -0.12289153230352914, "roe_avg2y": -0.5973910302963866, "roe_period_end": -0.43810796687836645 } }, { "accn": "0001558370-22-003015", "filed": "2022-03-08", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 4305000.0, "cash": 46859000.0, "eps_diluted": -2.75, "free_cash_flow": -20192000.0, "net_income": -88288000.0, "operating_cash_flow": -15887000.0, "operating_income": -91095000.0, "revenue": 7619000.0, "stockholders_equity": 46446000.0, "total_assets": 177029000.0, "total_liabilities": 130583000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.811501528656935, "revenue_growth_yoy": -0.2482486433152442, "roa_avg2y": -0.48844555830332, "roa_period_end": -0.4987205486106796, "roe_avg2y": -0.9782766472572951, "roe_period_end": -1.9008741334022305 } }, { "accn": "0001558370-21-001865", "filed": "2021-02-25", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3985000.0, "cash": 31530000.0, "free_cash_flow": -65335000.0, "net_income": -70698000.0, "operating_cash_flow": -61350000.0, "operating_income": -71863000.0, "revenue": 10135000.0, "stockholders_equity": 134051000.0, "total_assets": 184477000.0, "total_liabilities": 50426000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.37617026355640765, "revenue_growth_yoy": -0.28727144866385373, "roa_avg2y": -0.3780207088489826, "roa_period_end": -0.38323476639364257, "roe_avg2y": -0.5237412630151904, "roe_period_end": -0.5273962894719174 } }, { "accn": "0001558370-20-001974", "filed": "2020-03-03", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 5029000.0, "cash": 36641000.0, "free_cash_flow": -47511000.0, "net_income": -40193000.0, "operating_cash_flow": -42482000.0, "operating_income": -41299000.0, "revenue": 14220000.0, "stockholders_equity": 135922000.0, "total_assets": 189566000.0, "total_liabilities": 53644000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3946675299068583, "roa_period_end": -0.21202641823955773, "roe_period_end": -0.29570636100116243 } } ], "latest_filing": { "accn": "0001104659-26-025197", "filed": "2026-03-09", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2836", "sic_description": "Biological Products, (No Diagnostic Substances)", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001640266.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001640266.json" }, "ticker": "VYGR" }